Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML
Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML
复制标题
DOI:
10.1182/blood-2007-08-109058
复制
发表时间:
2008-03-01
期刊:
影响因子:
20.3
通讯作者:
Debatin, Klaus-Michael
中科院分区:
文献类型:
--
作者:
Meyer, Lueder H.;Queudeville, Manion;Debatin, Klaus-Michael
Recently we reported that intact apoptosis signaling is indicative of favorable outcome in childhood acute lymphoblastic leukemia. Here we addressed this issue in 45 pediatric acute myeloid leukemia patients analyzing 2 core apoptogenic events: cytochrome c release and caspase-3 activation. In patients with good prognosis cytochrome c release was clearly found to be caspase-dependent and correlated with activated caspase-3, indicating that activation of initiator or amplifier caspases such as caspase-8 together with an intact apoptosome function are elementary for favorable outcome. The functional integrity of this apoptogenic checkpoint is reflected by the parameter caspase-dependent cytochrome c-related activation of caspase-3 (CRAC(dep)). Patients with positive CRACdep values (intact signaling) exhibited superior survival compared with CRAC(deP) negative patients (deficient signaling). Thus, the propensity to undergo apoptosis of leukemia cells is an important feature for favorable treatment outcome and may serve as an additional stratification tool for pediatric AML patients. This trial was registered at www. ClinicalTrials.gov as #NCT00111345.